Malin (DUB:MLC) Gross Profit : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Malin Gross Profit?

Malin's gross profit for the six months ended in Dec. 2023 was €0.00 Mil. Malin's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Malin's gross profit for the six months ended in Dec. 2023 was €0.00 Mil. Malin's Revenue for the six months ended in Dec. 2023 was €0.00 Mil. Therefore, Malin's Gross Margin % for the quarter that ended in Dec. 2023 was N/A%.

Malin had a gross margin of N/A% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 9 years, the highest Gross Margin % of Malin was 27.32%. The lowest was 10.79%. And the median was 21.49%.

Malin Gross Profit Historical Data

The historical data trend for Malin's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malin Gross Profit Chart

Malin Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

Get a 7-Day Free Trial

7.50

10.20

Malin Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Profit	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of Malin's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Malin's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Malin's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Malin's Gross Profit distribution charts can be found below:

* The bar in red indicates where Malin's Gross Profit falls into.

Malin Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Malin's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0	-	0
	=	0.00

Malin's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0	-	0
	=	0.00

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Malin's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	0.00	/	0
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Malin (DUB:MLC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Malin had a gross margin of N/A% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

Malin Gross Profit Related Terms

Thank you for viewing the detailed overview of Malin's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Malin (DUB:MLC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Malin Corporation PLC (DUB:MLC) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

0Y71:UK

Address

50 Richmond Street South, The Lennox Building, Dublin, IRL, D02 FK02

Website

http://www.malinplc.com

Malin Corporation PLC is a global life sciences company. Its investee companies are in science and discovery, clinical and commercial sectors. The company's approach is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-trade sale operating businesses in the life sciences industry. The company derives all of its revenue from its subsidiary. Its subsidiary income is derived from the sale of pharmaceutical products.

Malin (DUB:MLC) Headlines

No Headlines